Concepedia

Claire Quaghebeur

CQ

Statistics

Publications

2

Citations

463

H-Index

2

Active since

2022

Affiliations

Institut Jules Bordet(Current)

Claire Quaghebeur is an author at Institut Jules Bordet specializing in oncology, germline cancer susceptibility, and brca mutations.

Publications per year

2022–2024

2

Publications

2

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Claire Quaghebeur et al. · Journal for ImmunoTherapy of Cancer · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2